Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature

TitleSpontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature
Publication TypeJournal Article
Year of Publication2006
AuthorsNuamah NM, Goker H, Kilic YA, Dagmoura H, Cakmak A
JournalHaematologica
Volume91
Issue5 Suppl
PaginationECR08
Date PublishedMay
ISSN1592-8721 (Electronic) 0390-6078 (Linking)
Accession Number16709516
Keywords*Living Donors, *Peripheral Blood Stem Cell Transplantation, Abdominal Pain / etiology, Adult, Female, Filgrastim / *adverse effects, Hematopoietic Stem Cell Mobilization / *adverse effects, Hemoperitoneum / etiology, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive / surgery, Male, Rupture, Spontaneous, Splenectomy, Splenic Rupture / diagnosis / *etiology / surgery, Splenomegaly / chemically induced
Abstract

Human granulocyte colony-stimulating factor (G-CSF) is a hematopoietic hormone promoting the growth, proliferation, differentiation and maturation of myeloid and leukocytic lineages. G-csfs have been used to improve granulocyte count in neutropenic patients, reduce the incidence and duration of neutropenia in patients receiving cytotoxic chemotherapy and to mobilize peripheral blood stem cells prior to leukapheresis for using in both autologous and allogeneic hematopoietic cell transplantation. In general, side-effects are mild to moderate and life threatening side-effects like splenic rupture are very rare. We herein, report a case of spontaneous splenic rupture secondary to high-dose G-CSF use (20 mcg/kg/day), in a healthy female allogeneic donor of peripheral-blood stem cell (PBSC) .

Notify Library Reference ID1094

Related Incidents